repaglinide, a new oral hypoglycemic for type 2 diabetes

You'll start to see ads for repaglinide, a new oralhypoglycemic for type 2 diabetes...from Novo Nordisk.

They're promoting it in the U.S. under the brand name, Prandin.But they'll probably use a different name in Canada...because"Prandin" is too similar to Prandase (acarbose).

Repaglinide is the first in a new class...the meglitinides.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote